Patent: 9,679,115

Summary for Patent: 9,679,115

Title:	Methods and devices for reducing transfusions during or after surgery and for improving quality of life and function in chronic disease
Abstract:	The present Invention relates to methods of treating subjects preparing to undergo surgery or methods of treating chronic disease and methods for reducing transfusions and a computer readable storage medium and a physical computing device for carrying out these methods which include: a) receiving a profile of said subject, in a physical computing device, including a level of hemoglobin of said subject, level of creatinine of said subject, and information regarding current or past history of disease; b) applying said level of hemoglobin and said level of creatinine, in said physical computing device, to determine level of transfusion risk; c) applying said information regarding current or past history of disease of said subject, in said physical computing device, to determine level of comorbidity; d) applying said level of hemoglobin, said level of transfusion risk, and said level of comorbidity, in said physical computing device, to determine a patient care plan.
Inventor(s):	Frey; Kathrine P. (Edina, MN)
Assignee:
Application Number:	13/576,874
Patent Claims:	see list of patent claims

Details for Patent 9,679,115

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Amgen, Inc.	EPOGEN/PROCRIT	epoetin alfa	Injection	103234	06/01/1989		2030-02-02
Amgen, Inc.	EPOGEN/PROCRIT	epoetin alfa	Injection	103234			2030-02-02
Amgen, Inc.	PROCRIT	epoetin alfa	Injection	103234			2030-02-02
Amgen, Inc.	ARANESP	darbepoetin alpha	Injection	103951	09/17/2001		2030-02-02
Amgen, Inc.	ARANESP	darbepoetin alpha	Injection	103951	07/19/2002		2030-02-02
Amgen, Inc.	ARANESP	darbepoetin alpha	Injection	103951	12/17/2002		2030-02-02